膀胱影像报告和数据系统评估膀胱肿瘤肌层浸润的验证
本研究回顾性纳入2015年1月至2019年3月经多参数MR检查的297例患者共339个肿瘤,由两名放射科医生以VI-RADS评分≥4和≥3为阈值评估肌层浸润。总体VI-RADS评分以≥4为阈值诊断肌层浸润的敏感度为91.3%、特异度为76.0%、准确率为80.2%,结论认为VI-RADS诊断肌层浸润肿瘤总体表现良好。
要点
- VI-RADS评分以≥4为阈值诊断肌层浸润的敏感度为91.3%、特异度为76.0%。
- 以≥3为阈值时敏感度升至94.6%,但特异度降至43.9%。
- T2W、DW和DCE三种MR序列在病灶层面的观察者间一致性均极好。
核心结论
- VI-RADS在诊断肌层浸润性膀胱肿瘤方面总体表现良好。
研究设计与样本
- 回顾性研究,纳入297例连续患者共339个肿瘤,均于2015年1月至2019年3月接受多参数MR检查,由两名放射科医生评估VI-RADS评分。
诊断标准与关键数值
- 总体VI-RADS评分以≥4为阈值:准确率80.2%(272/339),敏感度91.3%(85/93),特异度76.0%(187/246),阳性预测值83.3%(85/102),阴性预测值78.9%(187/237)。
- 总体VI-RADS评分以≥3为阈值:准确率63.7%(216/339),敏感度94.6%(125/132),特异度43.9%(91/207),阳性预测值51.6%(125/242),阴性预测值63.7%(91/97)。
- T2W和DW成像以 cutoff 值4诊断肌层浸润的准确率为79.3%(269/339),与总体评分80.2%(272/339)相似。
- 病灶层面观察者间一致性:T2W k=0.89,DW k=0.82,DCE k=0.85。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To retrospectively determine the diagnostic values of vesical imaging reporting and data system (VI-RADS) score for detecting muscle-invasive bladder tumors.
METHODS: This study included 297 consecutive patients with 339 tumors who previously diagnosed and subsequently underwent multiparametric MR imaging between January 2015 and March 2019. Two radiologists assessed the scores of muscle-invasive tumors using cutoff values of ≥ 4 and ≥ 3. Cutoff values for VI-RADS scores were estimated from the best operating points of the areas under the receiver operating characteristic curve analyses using the Youden J statistic. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy were calculated to assess the utility of VI-RADS for diagnosing muscle-invasive tumors.
RESULTS: Inter-observer agreement was excellent for three different MR imaging type at lesion level (k = 0.89 for T2W, k = 0.82 for DW, and k = 0.85 for DCE). At a cutoff value of 4, T2W and DW imaging had a diagnostic accuracy of 79.3% (269/339) for tumor lesions with muscle invasion, which was similar to an overall score of 80.2% (272/339). The overall VI-RAD score showed 80.2% accuracy (272/339), with a cutoff value of ≥ 4, yielding 91.3% sensitivity (85/93), 76.0% specificity (187/246), 83.3% PPV (85/102), and 78.9% NPV (187/237). When we considered an arbitrary overall score of ≥ 3 as the cutoff value, the accuracy was 63.7% (216/339); sensitivity, 94.6% (125/132); specificity, 43.9% (91/207); PPV, 51.6% (125/242); and NPV, 63.7% (91/97).
CONCLUSION: VI-RADS has an overall good performance in the diagnosis of muscle-invasive tumors.
引用
- Kim SH. Validation of vesical imaging reporting and data system for assessing muscle invasion in bladder tumor. Abdom Radiol (NY). 2020. PMID: 31422440. doi:10.1007/s00261-019-02190-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。